Andrea Marshall

Job Title

Associate Professor (Research Focussed)

Department

WMS - Warwick Clinical Trials Unit

Andrea.Marshall@warwick.ac.uk

Research Interests

Statistical design and analysis of randomised clinical trials, survival analysis, prognostic modelling and methods for dealing with missing data

Zarkar, A., Henderson, D., Carver, A., Heyes, G., Harrop, V., Stevenson, R., Kilkenny, J., Marshall, Andrea, Elbeltagi, N., Howard, H., 2023. First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer. BJUI Compass, 4 (4), pp. 464-472
van Hylckama Vlieg, Marte A. M., Nasserinejad, Kazem, Visser, Chantal, Bramer, Wichor M., Ashrani, Aneel A., Bosson, Jean-Luc, Crusan, Daniel J., D'Alessio, Andrea, Fluharty, Meg E., ??bietis, Valdis, Hansson, Per-Olof, Hara, Nobuhiro, Jara-Palomares, Luis, Kraaijpoel, Noémie, Mahé, Isabelle, Marshall, Andrea, Ogino, Yutaka, Otero, Remedios, Versmissen, Jorie, Klok, Frederikus A. et al (Select to open full list), 2023.

All authors for The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis : a systematic review and meta-analysis

van Hylckama Vlieg, Marte A. M., Nasserinejad, Kazem, Visser, Chantal, Bramer, Wichor M., Ashrani, Aneel A., Bosson, Jean-Luc, Crusan, Daniel J., D'Alessio, Andrea, Fluharty, Meg E., ??bietis, Valdis, Hansson, Per-Olof, Hara, Nobuhiro, Jara-Palomares, Luis, Kraaijpoel, Noémie, Mahé, Isabelle, Marshall, Andrea, Ogino, Yutaka, Otero, Remedios, Versmissen, Jorie, Klok, Frederikus A., Kruip, Marieke J. H. A., van der Rijt, Carin C. D., Geijteman, Eric C. T.

The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis : a systematic review and meta-analysis. eClinicalMedicine, 64
'Caiano, Lucia, 'Carrier, Marc, 'Marshall, Andrea, 'Young, Annie M., 'Ageno, Walter, 'Delluc, Aur?lien, 'Wang, Tzu?Fei, 2021. 'Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism : a systematic review and meta?analysis. Journal of Thrombosis and Haemostasis, 19 (10), pp. 2468-2479
Goyal, Amit, Puri, Shama, Marshall, Andrea, Valassiadou, Kalliope, Hoosein, Moin M., Carmichael, Amtul R., Erdelyi, Gabriella, Sharma, Nisha, Dunn, Janet A., York, Joanne, 2021. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients. Breast Cancer Research and Treatment, 185, pp. 433-440
Geach, R., Jones, L. I., Harding, S. A., Marshall, A. (Andrea), Taylor-Phillips, Sian, McKeown-Keegan, S., Dunn, Janet A., 2021. The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening : a systematic review and meta-analysis. Clinical Radiology, 76 (2), pp. 154.e11-154.e22
Kosmin, Michael, Padhani, Anwar R., Gogbashian, Andrew, Woolf, David, Ah-See, Mei-Lin, Ostler, Peter, Sutherland, Stephanie, Miles, David, Noble, Jillian, Koh, Dow-Mu, Marshall, Andrea, Dunn, Janet A., Makris, Andreas, 2020. Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology, 297 (3), pp. 622-629
Conefrey, C., Donovan, J. L., Stein, R. C., Paramasivan, S., Marshall, Andrea, Bartlett, J., Cameron, D. A., Campbell, Amy, Dunn, Janet A., Earl, H., Hall, P., Harmer, V., Hughes-Davies, L., Macpherson, I., Makris, A., Morgan, A., Pinder, S. E., Poole, Christopher J., Rea, D., Rooshenas, L., 2020. Strategies to improve recruitment to a de-escalation trial : a mixed-methods study of the OPTIMA prelim trial in early breast cancer. Clinical Oncology
Mulder, Frits I., Bosch, Floris T. M., Young, Annie M., Marshall, Andrea, McBane, Robert D., Zemla, Tyler, Carrier, Marc, Kamphuisen, Pieter W., Bossuyt, Patrick M., Buller, Harry R., Weitz, Jeffrey I., Middeldorp, Saskia, van Es, Nick, 2020. Direct oral anticoagulants for cancer-associated venous thromboembolism : a systematic review and meta-analysis. Blood, 136 (12), pp. 1433-1441
Annett, Stephanie, Moore, Gillian, Short, Amy, Marshall, Andrea, McCrudden, Cian, Yakkundi, Anita, Das, Sudipto, McCluggage, W. Glenn, Nelson, Laura, Harley, Ian, Moustafa, Nermeen, Kennedy, Catherine J., deFazio, Anna, Brand, Alison, Sharma, Raghwa, Brennan, Donal, O'Toole, Sharon, O'Leary, John, Bates, Mark, O'Riain, Ciarán et al (Select to open full list), 2020.

All authors for FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

Annett, Stephanie, Moore, Gillian, Short, Amy, Marshall, Andrea, McCrudden, Cian, Yakkundi, Anita, Das, Sudipto, McCluggage, W. Glenn, Nelson, Laura, Harley, Ian, Moustafa, Nermeen, Kennedy, Catherine J., deFazio, Anna, Brand, Alison, Sharma, Raghwa, Brennan, Donal, O'Toole, Sharon, O'Leary, John, Bates, Mark, O'Riain, Ciarán, O'Connor, Darran, Furlong, Fiona, McCarthy, Helen, Kissenpfennig, Adrien, McClements, Lana, Robson, Tracy

FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. British Journal of Cancer, 122, pp. 361-371
Marshall, Andrea, Levine, Mark, Hill, Catherine, Hale, Danielle, Thirlwall, Jenny, Wilkie, Veronica, French, Karen, Kakkar, Ajay K., Lokare, Anand, Maraveyas, Anthony, Chapman, Oliver, Arif, Azra, Petrou, Stavros, Maredza, Mandy, Hobbs, FD Richard, Dunn, Janet A., Young, Annie M., 2020. Treatment of cancer-associated venous thromboembolism : 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D Trial. (SELECT-D: 12m). Journal of Thrombosis and Haemostasis, 18 (4), pp. 905-915
Wan, Jonathan C. M., Heider, Katrin, Gale, Davina, Murphy, Suzanne, Fisher, Eyal, Mouliere, Florent, Ruiz-Valdepenas, Andrea, Santonja, Angela, Morris, James, Chandrananda, Dineika, Marshall, Andrea, Gill, Andrew B., Chan, Pui Ying, Barker, Emily, Young, Gemma, Cooper, Wendy N., Hudecova, Irena, Marass, Francesco, Mair, Richard, Brindle, Kevin M. et al (Select to open full list), 2020.

All authors for ctDNA monitoring using patient-specific sequencing and integration of variant reads

Wan, Jonathan C. M., Heider, Katrin, Gale, Davina, Murphy, Suzanne, Fisher, Eyal, Mouliere, Florent, Ruiz-Valdepenas, Andrea, Santonja, Angela, Morris, James, Chandrananda, Dineika, Marshall, Andrea, Gill, Andrew B., Chan, Pui Ying, Barker, Emily, Young, Gemma, Cooper, Wendy N., Hudecova, Irena, Marass, Francesco, Mair, Richard, Brindle, Kevin M., Stewart, Grant D., Abraham, Jean E., Caldas, Carlos, Rassl, Doris M., Rintoul, Robert C., Alifrangis, Constantine, Middleton, Mark R., Gallagher, Ferdia A., Parkinson, Christine, Durrani, Amer, McDermott, Ultan, Smith, Christopher G., Massie, Charles, Corrie, Pippa G., Rosenfeld, Nitzan

ctDNA monitoring using patient-specific sequencing and integration of variant reads. Science Translational Medicine, 12 (548)
Fane, M., Ecker, B., Kaur, A., Marino, G., Alicea, G., Douglass, S., Webstr, M., Marshall, A. (Andrea)?, Colling, R., Espinosa, O., Coupe, N., Campo, L., Maroo, N., Middleton, M., Corrie, P., Xu, X., Karakousis, G., Weeraratna, A., 2020. SFRP2 supersedes VEGF as an age-related driver of angiogenesis in melanoma, affecting response to anti-VEGF therapy in older patients. Clinical Cancer Research, 26 (21), pp. 5709-5719
Zarkar, A., Marshall, Andrea, Davies, A., Ford, D., James, N. D., Dunn, Janet A., 2019. Cabazitaxel in platinum pre-treated patients with locally advanced or metastatic transitional cell carcinoma who developed disease progression after platinum based chemotherapy : results of the phase II CAB-B1 trial. International Journal of Cancer Research & Therapy, 4 (4)
Jones, Lyn I., Geach, Rebecca, Harding, Sam A., Foy, Christopher, Taylor, Victoria, Marshall, Andrea, Taylor-Phillips, Sian, Dunn, Janet A., 2019. Can mammogram readers swiftly and effectively learn to interpret first post-contrast acquisition subtracted (FAST) MRI, a type of abbreviated breast MRI? : a single centre data-interpretation study. The British Journal of Radiology, 92
Couper, Keith, Kimani, Peter K., Gale, Chris P., Quinn, Tom., Squire, Iain B., Marshall, A. (Andrea)?, Black, John J. M., Cooke, Matthew, Ewings, Bob, Long, John, Perkins, Gavin D., 2018. Variation in outcome of hospitalised patients with out-of-hospital cardiac arrest from acute coronary syndrome : a cohort study. Health Services and Delivery Research, 6 (14)
Corrie, Pippa G., Marshall, A. (Andrea)?, Nathan, P D., Lorigan, P., Gore, M., Tahir, S., Faust, G., Kelly, C. G., Marples, M., Danson, S. J., Marshall, E., Houston, S. J., Board, R E., Waterston, A. M., Nobes, J. P., Harries, M., Kumar, S., Goodman, A., Dalgleish, A., Martin-Clavijo, A. et al (Select to open full list), 2018.

All authors for Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial

Corrie, Pippa G., Marshall, A. (Andrea)?, Nathan, P D., Lorigan, P., Gore, M., Tahir, S., Faust, G., Kelly, C. G., Marples, M., Danson, S. J., Marshall, E., Houston, S. J., Board, R E., Waterston, A. M., Nobes, J. P., Harries, M., Kumar, S., Goodman, A., Dalgleish, A., Martin-Clavijo, A., Westwell, S., Casasola, R., Chao, D., Maraveyas, A., Patel, P. M., Ottensmeier, C. H., Farrugia, D., Humphreys, A., Eccles, B., Young, G., Barker, E. O., Harman, C., Weiss, M., Myers, K. A., Chhabra, A., Rodwell, S. H., Dunn, Janet A., Middleton, M. R.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8), pp. 1843-1852
Couper, Keith, Kimani, Peter K., Gale, Chris P., Quinn, Tom, Squire, Iain B., Marshall, A. (Andrea)?, Black, John J. M., Cooke, Matthew, Ewings, Bob, Long, John, Perkins, Gavin D., 2018. Patient, health service factors and variation in mortality following resuscitated out-of-hospital cardiac arrest in acute coronary syndrome : analysis of the Myocardial Ischaemia National Audit Project. Resuscitation, 124, pp. 49-57
Lipplaa, Astrid, Fernandes, Ricardo, Marshall, Andrea, Lorigan, Paul, Dunn, Janet A., Myers, Kevin A, Barker, Emily, Newton-Bishop, Julia, Middleton, Mark R., Corrie, Pippa G., 2018. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British Journal of Cancer, 119, pp. 793-800
Jepson, Marcus, Elliott, Daisy, Conefrey, Carmel, Wade, Julia, Rooshenas, Leila, Wilson, Caroline, Beard, David, Blazeby, Jane M., Birtle, Alison, Halliday, Alison, Stein, Rob, Donovan, Jenny L., Beard, David, Carr, Andrew, Cook, Jonathan, Cooper, Cushla, Dean, Benjamin, Donovan, Jenny L., Gray, Alastair, Gwilym, Stephen et al (Select to open full list), 2018.

All authors for An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

Jepson, Marcus, Elliott, Daisy, Conefrey, Carmel, Wade, Julia, Rooshenas, Leila, Wilson, Caroline, Beard, David, Blazeby, Jane M., Birtle, Alison, Halliday, Alison, Stein, Rob, Donovan, Jenny L., Beard, David, Carr, Andrew, Cook, Jonathan, Cooper, Cushla, Dean, Benjamin, Donovan, Jenny L., Gray, Alastair, Gwilym, Stephen, Judge, Andrew, Merritt, Naomi, Moser, Jane, Rees, Jonathan, Rombach, Ines, Savulescu, Julian, Tracey, Irene, Wartolowska, Karolina, Blazeby, Jane M., Barham, Paul, Brookes, Sara T., Crosby, Tom, Donovan, Jenny L., Falk, Stephen J., Griffin, S. Michael, Hollingworth, William, Hollowood, Andrew D., Krysztopik, Richard, Lewis, Wyn, Nicklin, Jo, Streets, Christopher, Strong, Sean, Titcomb, Dan, Williams, Geraint, Birtle, Alison, Bryan, Rik, Catto, James, Chester, John, Donovan, Jenny L., French, Ann, Hall, Emma, Harris, Chris, Johnson, Mark, Jones, Rob, Keeley, Francis, Kirkbank, Tony, Kockelbergh, Roger, Lewis, Rebecca, Newton, Michelle, Powles, Thomas, Waters, Rachel, Winterbottom, Andrew, Halliday, Alison, Becquemin, Jean-Pierre, Belli, Anna, Bosiers, Marc, Cao, Piergiorgio, Davies, Christina, Donovan, Jenny L., Gray, Alastair, Gough, Michael, Hayter, Elizabeth, Leopold, Peter, McDonald, Sumaira, Michaels, Jonathan, Mihaylova, Borislava, Peto, Richard, Robertson, Steven, Rothwell, Peter, Scott, Rachael, Thomas, Dafydd, Vermassen, Frank, Stein, Rob, Bartlett, John, Cameron, David, Campbell, Amy, Canney, Peter, Donovan, Jenny L., Dunn, Janet, Earl, Helena, Falzon, Mary, Francis, Adele, Hall, Peter, Harmer, Victoria, Higgins, Helen, Hiller, Louise, Hughes-Davies, Luke, Hulme, Claire, Macpherson, Iain, Makris, Andreas, Marshall, Andrea, McCabe, Christopher, Morgan, Adrienne, Pinder, Sarah, Poole, Christopher J., Rea, Daniel, Stallard, Nigel

An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment. Journal of Clinical Epidemiology, 99, pp. 75-83
Lee, R. J., Gremel, G., Marshall, A. (Andrea)?, Myers, K. A., Fisher, N., Dunn, Janet A., Dhomen, N., Corrie, P. G., Middleton, M. R., Lorigan, P., Marais, R., 2018. Circulating tumor DNA predicts survival in patients with resected high risk stage II/III melanoma. Annals of Oncology, 29 (2), pp. 490-496
Fackrell, D., Marshall, A. (Andrea)?, Mistry, Pankaj, Dunn, Janet A., De Santis, Maria, Ford, D., Zarkar, A., 2018. Radical treatment of muscle-invasive bladder cancer-are options equal?. Journal of Radiation Oncology, 7 (2), pp. 181-186
Young, Annie M., Marshall, Andrea, Thirlwall, Jenny, Chapman, Oliver, Lokare, Anand, Hill, Catherine, Hale, Danielle, Dunn, Janet A., Lyman, Gary H., Hutchinson, Charles, MacCallum, Peter, Kakkar, Ajay, Hobbs, F. D. Richard, Petrou, Stavros, Dale, Jeremy, Poole, Christopher J., Maraveyas, Anthony, Levine, Mark, 2018. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism : results of a randomized trial (SELECT-D). Journal of Clinical Oncology, 36 (20), pp. 2017-2023
Janowitz, Tobias, Williams, Edward H., Marshall, Andrea, Ainsworth, Nicola, Thomas, Peter B., Sammut, Stephen J., Shepherd, Scott, White, Jeff, Mark, Patrick B., Lynch, Andy G., Jodrell, Duncan I., Tavaré, Simon, Earl, Helena, 2017. New model for estimating glomerular filtration rate in patients with cancer. Journal of Clinical Oncology, 35 (24), pp. 2798-2805
Mistry, Pankaj, Dunn, Janet A., Marshall, A. (Andrea), 2017. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines. BMC Medical Research Methodology, 17 (1)
Pinder, S. E., Campbell, Amy, Bartlett, J. M. S., Marshall, A. (Andrea)?, Allen, D., Falzon, M., Dunn, Janet A., Makris, A., Hughes-Davies, L., Stein, R. C., 2017. Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial. British Journal of Cancer, 116, pp. 859-863
Meads, David M., Marshall, A. (Andrea)?, Hulme, Claire T., Dunn, Janet A., Ford, Hugo E. R., 2016. The cost effectiveness of docetaxel and active symptom control versus active symptom control alone for refractory oesophagogastric adenocarcinoma : economic analysis of the COUGAR-02 trial. PharmacoEconomics, 34 (1), pp. 33-42
Bartlett, John M. S., Bayani, Jane, Marshall, A. (Andrea)?, Dunn, Janet A., Campbell, Amy, Cunningham, Carrie, Sobol, Monika S., Hall, Peter S., Poole, Christopher J., Cameron, David A., Earl, Helena M., Rea, Daniel W., Macpherson, Iain R., Canney, Peter, Francis, Adele, McCabe, Christopher, Pinder, Sarah E., Hughes-Davies, Luke, Makris, Andreas, Stein, Robert C., 2016. Comparing breast cancer multiparameter tests in the OPTIMA Prelim Trial : no test is more equal than the others. Journal of the National Cancer Institute, 108 (9)
Young, Annie M., Phillips, Jennifer, Hancocks, N. Helen, Hill, Catherine, Joshi, Neya, Marshall, A. (Andrea)?, Grumett, Joanne, Dunn, Janet A., Lokare, A., Chapman, O., 2016. OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Thrombosis Research, 140, pp. S172-S173
Francis, Adele, Stein, Robert C., Marshall, A. (Andrea?), Rea, Daniel W., Cameron, David A., Macpherson, Iain R., Earl, Helena M., Poole, Christopher J., Hall, Peter S., Bartlett, John M. S., Rooshenas, Leila, Morgan, Adrienne, Harmer, Victoria, Donovan, Jenny, Hulme, Claire, McCabe, Christopher, Pinder, Sarah E., Hughes-Davies, Luke, Makris, Andreas, Dunn, Janet A., 2016. OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis) : A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions. European Journal of Surgical Oncology (EJSO), 42 (5), pp. S9-S10
Janowitz, Tobias, Thuss-Patience, Peter, Marshall, A. (Andrea)?, Kang, Jung Hun, Connell, Claire, Cook, Natalie, Dunn, Janet A., Park, Se Hoon, Ford, Hugo, 2016. Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma : a meta-analysis of patient-level data. British Journal of Cancer, 114 (4), pp. 381-387
Stein, Robert C., Dunn, Janet A., Bartlett, John M. S., Campbell, Amy, Marshall, A. (Andrea)?, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E., Cameron, David A., Stallard, Nigel, Donovan, Jenny L., McCabe, Christopher, Hughes-Davies, Luke, Makris, Andreas, 2016. R : OPTIMA prelim : a randomised feasibility study of personalised care in the treatment of women with early breast cancer. Health Technology Assessment, 20 (10), pp. 1-202
Malczewski, Agnieszka, Marshall, A. (Andrea)?, Payne, Miranda J., Mao, Lili, Bafaloukos, Dimitrios, Si, Lu, Pectasides, Dimitrios, Fountzilas, George, Guo, Jun, Gogas, Helen, Middleton, Mark R., 2016. Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence : meta-analysis of three trials. Cancer Medicine, 5 (1), pp. 17-23
Nelson, Laura, McKenn, Hayley D., Marshall, A. (Andrea)?, Mulrane, Laoighse, Starczynski, Jane, Storr, Sarah J., Lanigan, Fiona, Byrne, Christopher, Arthur, Ken, Hegarty, Shauna, Ali, Ahlam Abdunnabi, Furlong, Fiona, McCarthy, Helen, Ellis, Ian O., Green, Andrew R., Rakha, Emad, Young, Leonie, Kunkler, Ian, Thomas, Jeremy, Jack, Wilma et al (Select to open full list), 2015.

All authors for FKBPL : a marker of good prognosis in breast cancer

Nelson, Laura, McKenn, Hayley D., Marshall, A. (Andrea)?, Mulrane, Laoighse, Starczynski, Jane, Storr, Sarah J., Lanigan, Fiona, Byrne, Christopher, Arthur, Ken, Hegarty, Shauna, Ali, Ahlam Abdunnabi, Furlong, Fiona, McCarthy, Helen, Ellis, Ian O., Green, Andrew R., Rakha, Emad, Young, Leonie, Kunkler, Ian, Thomas, Jeremy, Jack, Wilma, Cameron, David, Jirström, Karin, Yakkundi, Anita, McClements, Lana, Martin, Stewart G., Gallagher, William M., Dunn, Janet A., Bartlett, John, O?Connor, Darran, Robson, Tracy

FKBPL : a marker of good prognosis in breast cancer. Oncotarget, 6 (14), pp. 12209-12223
Ford, Hugo, Marshall, A. (Andrea), Bridgewater, John A., Janowitz, Tobias, Coxon, Fareeda Y., Wadsley, Jonathan, Mansoor, Wasat, Fyfe, David, Madhusudan, Srinivasan, Middleton, Gary W., Swinson, Daniel, Falk, Stephen, Chau, Ian, Cunningham, David, Kareclas, Paula, Cook, Natalie, Blazeby, Jane M., Dunn, Janet A., 2014. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02) : an open-label, phase 3 randomised controlled trial. The Lancet Oncology, 15 (1), pp. 78-86
Corrie, Pippa G., Marshall, A. (Andrea)?, Dunn, Janet A., Middleton, Mark R., Nathan, Paul D., Gore, Martin, Davidson, Neville, Nicholson, Steve, Kelly, Charles G., Marples, Maria, Danson, Sarah J., Marshall, Ernest, Houston, Stephen J., Board, Ruth E., Waterston, Ashita M., Nobes, Jenny P., Harries, Mark, Kumar, Satish, Young, Gemma, Lorigan, Paul, 2014. Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M) : preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. The Lancet Oncology, 15 (6), pp. 620-630
Lu, Q., Zhuang, Q., Marshall, A. (Andrea)?, Kesaria, M., Beanland, R., Krier, A., 2014. InSb quantum dots for the mid-infrared spectral range grown on GaAs substrates using metamorphic InAs buffer layers. Semiconductor Science and Technology, 29 (7)
Abdelaziz, Mahmoud, Marshall, A. (Andrea)?, Kerr, Amy, Hussain, Khalid, Wotton, Robin, Bishay, Ehab, Kalkat, Maninder, Rajesh, Pala, Steyn, Richard, Naidu, Babu, 2014. Erratum : Does the revised cardiac risk index predict cardiac complications following elective lung resection?. Journal of Cardiothoracic Surgery, 9
Wason, J., Marshall, A. (Andrea)?, Dunn, Janet A., Stein, R. C., Stallard, Nigel, 2014. Adaptive designs for clinical trials assessing biomarker-guided treatment strategies. British Journal of Cancer, 110 (8), pp. 1950-1957
Dunn, Janet A., Donnelly, P. K., Marshall, A. (Andrea)?, Wilcox, M., Watson, E., Young, Annie M., Balmer, Claire E., Ramirez, M., Hartup, S., Maxwell, A.J., Evans, A. J., 2014. Follow-up in early breast cancer ? a surgical and radiological perceptive. Clinical Oncology, 26 (10), pp. 625-629
Wotton, Robin, Marshall, A. (Andrea), Kerr, Amy, Bishay, Ehab, Kalkat, Maninder, Rajesh, Pala, Steyn, Richard, Naidu, Babu, 2013. Does the revised cardiac risk index predict cardiac complications following elective lung resection?. Journal of Cardiothoracic Surgery, 8 (1)
Bradley, A., Marshall, A. (Andrea), Abdelaziz, M., Hussain, K., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A., Naidu, Babu V., 2012. Thoracoscore fails to predict complications following elective lung resection. European Respiratory Journal, Vol.40 (No.6), pp. 1496-1501
Ainsworth, N. L., Marshall, A. (Andrea)?, Hatcher, H., Whitehead, L., Whitfield, G. A., Earl, Helena M., 2012. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients. Annals of Oncology, 23 (7), pp. 1845-1853
Rughani, M. G., Swan, M. C., Adams, T. S., Marshall, A. (Andrea), Asher, R., Cassell, O. C., Middleton, M. (Mark), 2012. Sentinel node status predicts survival in thick melanomas : the Oxford perspective. European Journal of Surgical Oncology (EJSO), Vol.38 (No.10), pp. 936-942
Marshall, A. (Andrea), Altman, Douglas G., Holder, Roger L., 2010. Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model : a resampling study. BMC Medical Research Methodology, 10 (1)
Marshall, A. (Andrea), Altman, Douglas G., Royston, Patrick, Holder, Roger L., 2010. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Medical Research Methodology, Vol.10 (Article 7)
Cheah, N. L. C., Lupton, S., Marshall, A. (Andrea), Hartley, A., Glaholm, J., 2009. Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience. Clinical Oncology, Vol.21 (No.6), pp. 494-501
Marshall, A. (Andrea), Altman, Douglas G., Holder, Roger L., Royston, Patrick, 2009. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Medical Research Methodology, Vol.9 (Articl)
Marshall, A. (Andrea), Billingham, Lucinda J., Bryan, Stirling, 2009. Can we afford to ignore missing data in cost-effectiveness analyses?. European Journal of Health Economics, Vol.10 (No.1), pp. 1-3
Biswas, S., Wrigley, J., East, C., Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, P., Middleton, M. (Mark), Corrie, P., 2008. A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma : an update. ecancermedicalscience, Vol.2
Burton, Andrea, Billingham, Lucina Jane, Bryan, Stirling, 2007. Cost-effectiveness in clinical trials : using multiple imputation to deal with incomplete cost data. Clinical Trials, Vol.4 (No.2), pp. 154-161
Young, Annie M., Marsden, J., Goodman, A., Burton, Andrea, Dunn, Janet A., 2001. Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-a) in metastatic melanoma. Clinical Oncology, 13 (6), pp. 458-465

Young, Annie M., Phillips, J., Marshall, A., Grumett, J., Dunn, Janet A., Lowe, S., Chapman, O., Lokare, A., 2014. Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. 7th ITHIC, Published in Thrombosis Research, pp. S220-S220
Biswas, S., East, C., A'Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, Paul, Middleton, M. (Mark), Corrie, P., 2008. Adjuvant bevacizumab is safe treatment for melanoma patients at high risk of recurrence. 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008, Published in Annals of Oncology, pp. 245-246
Gray, R. G., Rea, Dean, Handley, K., Marshall, A. (Andrea), Pritchard, M. G., Perry, P., Earl, Helena M., Poole, Christopher J., Salman, A., Lee, M., 2008. aTTom (adjuvant Tamoxifen--To offer more?) : randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer--Preliminary results. 2008 ASCO Annual Meeting, Chicago, Illinois, 30 May-3 Jun 2008, Published in Journal of Clinical Oncology
Yu, L. -M., Burton, Andrea, Rivero-Arias, Oliver, 2007. Evaluation of software for multiple imputation of semi-continuous data. Workshop on Multiple Imputation, MRC Biostatist Unit, Cambridge, UK, 12-13 Apr 2005, Published in Statistical Methods in Medical Research, pp. 243-258

Jones, Lyn I., Taylor-Phillips, Sian, Geach, Rebecca, Harding, Sam A., Marshall, ?A., McKeown-Keegan, Sadie, Dunn, Janet A., 2022. Re: The potential of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening : a systematic review and meta-analysis. A reply. Clinical Radiology, W.B. Saunders Co. Ltd, pp. 73-75
Stein, R. C., Makris, A., Hughes-Davies, L., Macpherson, I. R., Hall, P. S., Cameron, D. A., Earl, H. M., Pinder, S. E., Poole, C. J., Rea, D. W., McIntosh, S., Harmer, V., Morgan, A., Rooshenas, L., Conefrey, C., Donovan, J. L., Hulme, C, McCabe, Chris, Stallard, Nigel, Campbell, A. et al (Select to open full list), 2018.

All authors for OPTIMA : A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer

Stein, R. C., Makris, A., Hughes-Davies, L., Macpherson, I. R., Hall, P. S., Cameron, D. A., Earl, H. M., Pinder, S. E., Poole, C. J., Rea, D. W., McIntosh, S., Harmer, V., Morgan, A., Rooshenas, L., Conefrey, C., Donovan, J. L., Hulme, C, McCabe, Chris, Stallard, Nigel, Campbell, A., Higgins, Helen B., Bartlett, J. M. S., Marshall, A. (Andrea)?, Dunn, Janet A.

OPTIMA : A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer. Cancer Research, American Association of Cancer Research
Young, Annie M., Marshall, A. (Andrea)?, Thirlwall, Jenny, Chapman, O., Lokare, A., Hills, Claire E., Hale, D., Dunn, Janet A., Kakkar, A., Levine, M., Select-d Collaborative, Group, 2018. Anticoagulation therapy in SELECTeD cancer patients at risk of recurrence of venous thromboembolism : results of the 'select-d' Pilot Trial. Thrombosis Research, Pergamon-Elsevier Science Ltd
Dunn, Janet A., Marshall, A. (Andrea)?, Ramirez, M., Evans, A., Donnelly, P., 2017. Value of a sister observational cohort alongside a randomised controlled trial with an internal feasibility phase. Trials, Biomed Central Ltd
Mistry, Pankaj, Dunn, Janet A., Marshall, A. (Andrea)?, 2017. A literature review of the use of adaptive design methods in oncology trials. Trials, Biomed Central Ltd
Stein, R. C., Makris, A., Hughes-Davies, L., Bartlett, J. M. S., Marshall, A. (Andrea)?, Hall, P. S., Campbell, A., Pinder, S. E., Cameron, D. A., Rea, D., Earl, H., MacPherson, I., Poole, C., Canney, P., Francis, A., Morgan, A., Stallard, Nigel, Hulme, C., McCabe, C., Dunn, Janet A., 2015. Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study. European Journal of Cancer Care, Wiley-Blackwell Publishing Ltd
Young, Annie M., Phillips, Jessica M., Hancocks, H., Marshall, A. (Andrea)?, Grumett, J., Dunn, Janet A., Chapman, Oliver, 2015. Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Journal of Clinical Oncology, American Society of Clinical Oncology
Hall, P., Smith, A., Hulme, C., Vargas-Palacios, A., Dunn, Janet A., Marshall, A. (Andrea)?, Bartlett, J., Stein, R., Cameron, D., McCabe, C., 2015. The use of early decision modelling and value of information analysis in an adaptive trial design : results from the OPTIMA preliminary study. Trials, Biomed Central Ltd
Bartlett, J. M. S., Stein, R. C., Bayani, J., Marshall, A. (Andrea)?, Dunn, Janet A., Campbell, A. F., Cunningham, C., Sobol, M., Hall, P., Rooshenas, L., Morgan, A., Poole, Christopher J., Pinder, S. E., Cameron, D. A., Stallard, Nigel, Donovan, J., McCabe, C., Hughes-Davies, L., Makris, A., 2015. Comparison of multiparameter tests in the UK OPTIMA-Prelim trial. Cancer Research, American Association of Cancer Research
Hiller, Louise, Marshall, A. (Andrea)?, Dunn, Janet A., 2015. Assessing violations of the proportional hazards assumption in Cox regression : does the chosen method matter?. Trials, Biomed Central Ltd
Dunn, Janet A., Marshall, A. (Andrea)?, Campbell, Amy, Cameron, D., Earl, H., Macpherson, I., Poole, C., Rea, D., Francis, A., Harmer, V., Morgan, A., Stallard, Nigel, Makris, A., Hughes-Davies, L., Stein, R., 2015. Practicalities of using an adaptive design for decision making within the optima trial : optimal personalized treatment of early breast cancer using multi-parameter tests. Trials, Biomed Central Ltd
Young, Annie M., Dunn, Janet A., Chapman, O., Grumett, J., Marshall, A., Phillips, J., Lokare, A., 2014. SELECT-D : anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Journal of Clinical Oncology, American Society of Clinical Oncology
Corrie, P., Marshall, A. (Andrea)?, Goonewardena, M., Dunn, Janet A., Middleton, M. R., Nathan, P. D., Gore, M. E., Davidson, N., Nicholson, S., Kelly, C. G., Marples, M., Danson, S., Marshall, E., Houston, S., Board, R. E., Waterston, A. M., Nobes, J., Harries, M., Barber, J., Lorigan, P., 2013. Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence : preplanned interim results for the AVAST-M trial. Journal of Clinical Oncology, American Society of Clinical Oncology
Ford, H., Marshall, A. (Andrea)?, Wadsley, J., Coxon, F. Y., Mansoor, W., Bridgwater, J. A., Madhusudan, S., Falk, S., Middleton, G. W., Swinson, D., Chau, I., Thompson, J., Blazeby, J. M., Cunningham, D., Kareclas, P., Dunn, Janet A., 2013. COUGAR-02 : a randomized phase 111 study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma. Journal of Clinical Oncology, American Society of Clinical Oncology
Corrw, P., Marshall, A. (Andrea)?, Goonewardena, M., Dunn, Janet A., Middleton, M. R., Nathan, P. D., Gore, M. E., Davidson, N., Nicholson, S., Kelly, C. E. G., Marples, M., Damson, S., Marshall, E., Houston, S., Board, R. E., Waterston, A. M., Nobes, J., Harries, M., Barber, J., Lorigan, P., 2013. AVAST-M: Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence. Journal of Clinical Oncology, American Society of Clinical Oncology
Abdelaziz, M., Marshall, A. (Andrea)?, Hussain, K., Bradley, A., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A., Naidu, B., 2012. Can the thoracoscore and revised cardiac risk index predict outcomes?. Lung Cancer, Elsevier
Poole, Christopher J., Marshall, A. (Andrea)?, Higgins, Helen B., Fletcher, J., Williams, S. J., Lo, N., Fernando, I. N., Osborne, R., Crawford, S. M., Rafii, S., Gill, S., Dunn, Janet A., 2012. Neo-escape : Neoadjuvant extended sequential chemotherapy with adjuvant postoperative treatment for epithelial nonmucinous advanced inoperable peritoneal malignancy. Journal of Clinical Oncology, American Society of Clinical Oncology
Marshall, A. (Andrea), Dunn, Janet A., Fletcher, Julie, Higgins, Helen B., Poole, Christopher, 2011. The importance of planning for a seamless transition in an adaptive phase II randomised trial. Trials, Bio Med Central

Title	Funder	Award start	Award end
NIHR HTA via Derby NHS Tust: ATNEC?Axillary management in T1-3N1M0 breast cancer patients with FNA or core biopsy proven nodal metastases at presentation after NEoadjuvant Chemotherapy	National Institute for Health Research (DoH)	01 Mar 2020	28 Feb 2030
ATNEC Y6-10	National Institute for Health Research (DoH)	01 Mar 2020	28 Feb 2030
NIHR HTA Stage 2 via UHCW: Evaluation of PeRsOnalised PrEhabilitation in acute myeloid Leukaemia (PROPEL).	National Institute for Health Research (NIHR DoH)	01 Sept 2022	31 Aug 2027
NIHR EME NIHR150502 via Bristol: : Diagnostic yield study to determine whether an abbreviated form of breast Magnetic Resonance Imaging (FAST MRI) can detect breast cancers missed by screening mammography for women at population risk of breast cancer with average mammographic density following their initial screening mammogram	National Institute for Health Research (NIHR DoH)	01 May 2023	31 Oct 2026
Breast Cancer Now: Mammographic Density Study	Breast Cancer Now	01 Mar 2019	31 Aug 2024
Mammographic surveilance in breast cancer patients aged 50 years or older (Mammo-50) (RMRCT 1081) Extension.Linked to IDEATE 33985	National Institute for Health Research (NIHR DoH)	01 Jul 2022	31 Dec 2023
OPTIMA - 8 year extension	National Institute for Health Research (DoH)	01 Apr 2015	31 Mar 2023
Breast Cancer Now:SENTINUS: Multicentre phase II trial to assess technical feasibility and diagnostic performance of intradermal microbubbles and contrast-enhanced ultrasound (CEUS) plus core biopsy as a test to identify sentinel lymph node (SLN) metastases in patients with primary invasive breast cancer and a normal axillary grey-scale ultrasound. Lead by Maidstone NHS Trust	Breast Cancer Now	05 Oct 2020	04 Jan 2023
National Breast Imaging Academy : Mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers new to the interpretation of a shortened magnetic resonance imaging scan (MRI) of the breast called FAST MRI to support the delivery of a future multicentre trial of FAST MRI versus mammogram for breast cancer screening - (The FAST MRI Reader Training Study) Lead by North Bristol NHS Trust	National Breast Imaging Academy (NBIA)	01 Aug 2021	30 Jun 2022
Mammographic surveillance in breast cancer patients aged 50 years or older	National Institute for Health Research (DoH)	01 Mar 2013	28 Feb 2022
CRUK funded via Cambridge: AVAST-M - Extension	Cancer Research UK	01 Aug 2010	31 Dec 2019
The development and pilot trial of two programmes of rehabilitation for cancer survivors and unmet needs PRO REHAB. Recosting	National Institute for Health Research (DoH)	01 Mar 2013	29 Feb 2016
OPTIMA extra funds	National Institute for Health Research (DoH)	01 May 2015	31 Oct 2015
BAYER - Investigator led research proposal: SELECT-D Duration of anticoagulation therapy in SELECTeD patients with advanced cancer at risk of recurrence of venous thromboembolism -	Bayer plc	01 Oct 2012	30 Sept 2015
MRC DPFS via Queens University Belfast: Identifying markers of response to anti-oestrogen therapy	MRC	01 Feb 2011	31 Jan 2013
COUGAR 2 Extension - Andrea Marshall	Cancer Research UK	01 Nov 2010	31 Oct 2012

Warwick Medical School

Mrs Andrea Marshall

All authors for The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis : a systematic review and meta-analysis

All authors for FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

All authors for ctDNA monitoring using patient-specific sequencing and integration of variant reads

All authors for Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial

All authors for An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

All authors for FKBPL : a marker of good prognosis in breast cancer

All authors for OPTIMA : A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer